For patients on
Antihemophilic Factor (Recombinant)
You can continue Factor VIII treatment with Kogenate® FS
Antihemophilic Factor (Recombinant)
Important facts about Helixate FS and Kogenate FS
Kogenate FS and Helixate FS contain the same factor (active pharmaceutical ingredient and formulation) and are manufactured by Bayer in the same facility
Bayer has an agreement to supply this factor to CSL Behring, who markets it as Helixate FS
Bayer's supply agreement with CSL Behring will continue through December 31, 2017, at which point Helixate FS will no longer be manufactured by Bayer
Bayer will continue to manufacture Kogenate FS
Kogenate FS and Helixate FS have different reconstitution systems
Kogenate FS is covered by all major national insurance companies and is preferred by CVS/Caremark,* Express Scripts,† and UnitedHealthcare*
You can check with your insurance provider for any recent changes to the coverage status of Helixate FS
*On some commercial prescription plans.
†This pertains to Express Scripts's National Preferred and Basic Formularies.
This year, 7 out of 10 people who transitioned from Helixate FS treatment were prescribed Kogenate FS‡
‡Sources: Symphony Health claim database; specialty pharmacy aggregate data; 1/17 – 5/17. Percentage is derived from actual data from an existing data set, which may underestimate or overestimate actual percentage.
Talk to your healthcare provider to see if Kogenate FS may be appropriate for you and register for additional updates
Follow the 3 steps below to switch to Kogenate FS
1.Connect with Bayer Access Solutions to verify coverage of Kogenate FS and find out if you're eligible for co-pay assistance.§
Loyalty Programll: Redeem points to receive Kogenate FS at no cost if you experience gaps or challenges with insurance coverage
Introductory Enrollment Bonus—12 points: Enroll now during the introductory period through February 28, 2018, and get a year's worth of Loyalty points
8:00 AM–8:00 PM (ET)
Spanish-speaking Case Specialists are also available.
§Restrictions apply. Please click here or call 1-800-288-8374 for more information about the restrictions.
llPatients who have government insurance are not eligible for the loyalty and co-pay support programs.
2.See the features of the Kogenate FS reconstitution system:
Vial Adapter with built-in 15-micrometer filter
2.5 mL or 5.0 mL prefilled diluent syringe
25-gauge butterfly needle
Identical vial sizes as those offered with Helixate FS:
|250 IU||2000 IU|
|500 IU||3000 IU|
Watch the Vial Adapter in action
Please see full Prescribing Information for Kogenate FS.
Kogenate® FS Antihemophilic Factor (Recombinant) and Helixate® FS Antihemophilic Factor (Recombinant) are medicines used to replace clotting factor (factor VIII or antihemophilic factor) that is missing in people with hemophilia A.
Kogenate FS and Helixate FS are used to treat and control bleeding in adults and children with hemophilia A. Your healthcare provider may give you Kogenate FS or Helixate FS when you have surgery. Kogenate FS and Helixate FS can reduce the number of bleeding episodes in adults and children when used regularly (prophylaxis). Kogenate FS and Helixate FS can reduce the risk of joint damage in children without pre-existing joint damage when used regularly.
Kogenate FS and Helixate FS are not used to treat von Willebrand disease.
Important Safety Information
You should not use Kogenate FS or Helixate FS if you are allergic to rodents (like mice and hamsters) or are allergic to any ingredients in Kogenate FS or Helixate FS.
Tell your healthcare provider if you have been told you have heart disease or are at risk for heart disease.
You could have an allergic reaction to Kogenate FS or Helixate FS. Call your healthcare provider right away and stop treatment if you get rash or hives, itching, tightness of the chest or throat, difficulty breathing, light-headed, dizziness, nausea or a decrease in blood pressure.
Your body can make antibodies, called "inhibitors," against Kogenate FS or Helixate FS, which may stop Kogenate FS or Helixate FS from working properly. Consult with your healthcare provider to make sure you are carefully monitored with blood tests for the development of inhibitors to factor VIII.
Other common side effects of Kogenate FS and Helixate FS are local injection site reactions (pain, swelling, irritation at infusion site) and infections from implanted injection device. Tell your healthcare provider about any side effect that bothers you or does not go away.
Call your healthcare provider right away if bleeding is not controlled after using Kogenate FS or Helixate FS.
You are encouraged to report negative side effects or quality complaints of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.